Clinical Trials Browser

Phase 2 × Leukemia × ixazomib × Clear all

NCT02302846 2018-10-03

Study of MLN9708 as Maintenance Therapy for Patients With Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic Syndrome (MDS) in Remission

Phase 2 Terminated

5 enrolled 7 charts

Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Acute